Scientists Uncover ‘Game-Changing’ Therapy for Asthma Attacks
The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.
Too Old to Operate3d
Identification of Histopathologic Features in Allergic Contact Dermatitis
The following is a summary of “Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the ...
EsoCap announces publication of comprehensive Phase II results demonstrating ESO-101’s effectiveness in eosinophilic esophagitis
Detailed results of the ACESO Phase II study published in the peer-reviewed medical journal Alimentary Pharmacology & ...
Newsweek1mon
'Game-Changing' New Treatment for Asthma Is First in 50 Years
Bafadhel's team studied the effect of injecting patients with benralizumab, a lab-made protein designed to act like an antibody, targeting specific white blood cells called eosinophils to reduce ...